Harvoni 33.75mg/150mg oral pellets,1 x 28packets (Ledipasvir/Sofosbuvir)

Reference priceUSD $265.20Original source price: INR 22,100.00. Converted estimates are available by currency selection.

Brand	Harvoni
Manufacturer	Gilead Sciences GmbH
Prescription required	Yes

Description

Harvoni 33.75mg/150mg oral pellets,1 x 28packets(/) (Ledipasvir/Sofosbuvir) is a medicine catalog record in the MediPriceHub database. Active ingredient: Ledipasvir/Sofosbuvir. Clinical use summary: See the Benefits field on this page for the product-specific indication or intended use. That field is kept separate from catalog metadata so users can distinguish clinical information from packaging information. Manufacturer or supplier: Gilead Sciences GmbH. Therapeutic category: Medicine Library > Liver and Gallbladder Diseases > Hepatitis C drugs. Pack information: 33.75 / 150 1 x 28. Origin country or market: United States. This page is for medicine catalog reference only and should be read together with the approved prescribing information in the patient or buyer's country.

Benefits

HARVONI is indicated for the treatment of adults and pediatric patients 3 years of age and older with chronic hepatitis C virus (HCV) [see Dosage and Administration (2.2 and 2.3) and Clinical Studies ] : genotype 1, 4, 5, or 6 infection without cirrhosis or with compensated cirrhosis genotype 1 infection with decompensated cirrhosis, for use in combination with ribavirin genotype 1 or 4 infection who are liver transplant recipients without cirrhosis or with compensated cirrhosis, for use in combination with ribavirin

How to Use

Use Ledipasvir/Sofosbuvir under the supervision of a qualified healthcare professional. Take it by mouth only according to the approved label and the dose prescribed by a qualified healthcare professional. Do not start, stop, change the dose, split or crush a dosage form, mix with other medicines, or repeat a course unless the approved product information or a clinician confirms that it is appropriate. Check the local prescribing information for age limits, dose adjustments, missed-dose instructions, storage after opening or reconstitution, and monitoring requirements.

Specification

Active ingredient: Ledipasvir/Sofosbuvir. Pack size: 33.75 / 150 1 x 28. Pack unit: box. Manufacturer: Gilead Sciences GmbH. Origin country: United States. Source category: Medicine Library > Liver and Gallbladder Diseases > Hepatitis C drugs. Availability, prescription status, storage, and exact approved use may vary by country. Check the local product information before clinical or procurement decisions.

Side Effects

The available source record does not provide a clean, product-specific adverse-reaction list. Potential risks depend on the active ingredient, dose, route, treatment duration, and patient condition. Check the approved local prescribing information for the complete adverse-reaction profile, warnings, contraindications, and monitoring requirements. Seek urgent medical care for severe allergic symptoms, breathing difficulty, fainting, severe skin reactions, chest pain, serious bleeding, or rapidly worsening symptoms.

This information is for reference only. Consult a qualified healthcare professional before using any medicine.